Beam Therapeutics Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.22x
Net debt / equity: -0.03x
Debt / assets: 0.17x
Debt / EBITDA: -7.83x
Net debt / EBITDA: 1.17x

Liquidity & coverage

Current ratio: 16.99x
Quick ratio: 16.99x
Cash ratio: 16.25x
Interest coverage: -34.93x
EBITDA / interest: -3.01x
Working capital: $1.2B

Cash & dividend

FCF / debt: -1.53x
Cash flow / debt: -1.47x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: +7.1%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.